These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15713620)

  • 21. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival.
    Ueki K; Fruman DA; Brachmann SM; Tseng YH; Cantley LC; Kahn CR
    Mol Cell Biol; 2002 Feb; 22(3):965-77. PubMed ID: 11784871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of class IA phosphoinositide 3-kinase catalytic subunits p110 alpha and beta by protease-activated receptor 2 and beta-arrestins.
    Wang P; Kumar P; Wang C; Defea KA
    Biochem J; 2007 Dec; 408(2):221-30. PubMed ID: 17680774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of rs361072 in the phosphoinositide 3-kinase p110beta gene on whole-body glucose metabolism and subunit protein expression in skeletal muscle.
    Ribel-Madsen R; Poulsen P; Holmkvist J; Mortensen B; Grarup N; Friedrichsen M; Jørgensen T; Lauritzen T; Wojtaszewski JF; Pedersen O; Hansen T; Vaag A
    Diabetes; 2010 Apr; 59(4):1108-12. PubMed ID: 20107106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin induces SOCS-6 expression and its binding to the p85 monomer of phosphoinositide 3-kinase, resulting in improvement in glucose metabolism.
    Li L; Grønning LM; Anderson PO; Li S; Edvardsen K; Johnston J; Kioussis D; Shepherd PR; Wang P
    J Biol Chem; 2004 Aug; 279(33):34107-14. PubMed ID: 15123678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver.
    Miyake K; Ogawa W; Matsumoto M; Nakamura T; Sakaue H; Kasuga M
    J Clin Invest; 2002 Nov; 110(10):1483-91. PubMed ID: 12438446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered signaling and cell cycle regulation in embryonal stem cells with a disruption of the gene for phosphoinositide 3-kinase regulatory subunit p85alpha.
    Hallmann D; Trümper K; Trusheim H; Ueki K; Kahn CR; Cantley LC; Fruman DA; Hörsch D
    J Biol Chem; 2003 Feb; 278(7):5099-108. PubMed ID: 12435753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of phosphatidylinositol 3-kinase composed of p110beta-catalytic and p85-regulatory subunits with the small GTPase Rab5.
    Kurosu H; Katada T
    J Biochem; 2001 Jul; 130(1):73-8. PubMed ID: 11432782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha.
    Sun M; Hillmann P; Hofmann BT; Hart JR; Vogt PK
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15547-52. PubMed ID: 20713702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calorie Restriction-Induced Increase in Skeletal Muscle Insulin Sensitivity Is Not Prevented by Overexpression of the p55α Subunit of Phosphoinositide 3-Kinase.
    Martins VF; Tahvilian S; Kang JH; Svensson K; Hetrick B; Chick WS; Schenk S; McCurdy CE
    Front Physiol; 2018; 9():789. PubMed ID: 29997524
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin substrates 1 and 2 are corequired for activation of atypical protein kinase C and Cbl-dependent phosphatidylinositol 3-kinase during insulin action in immortalized brown adipocytes.
    Miura A; Sajan MP; Standaert ML; Bandyopadhyay G; Kahn CR; Farese RV
    Biochemistry; 2004 Dec; 43(49):15503-9. PubMed ID: 15581362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A biochemical mechanism for the oncogenic potential of the p110beta catalytic subunit of phosphoinositide 3-kinase.
    Dbouk HA; Pang H; Fiser A; Backer JM
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19897-902. PubMed ID: 21030680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes.
    Mauvais-Jarvis F; Ueki K; Fruman DA; Hirshman MF; Sakamoto K; Goodyear LJ; Iannacone M; Accili D; Cantley LC; Kahn CR
    J Clin Invest; 2002 Jan; 109(1):141-9. PubMed ID: 11781359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats.
    Anai M; Funaki M; Ogihara T; Terasaki J; Inukai K; Katagiri H; Fukushima Y; Yazaki Y; Kikuchi M; Oka Y; Asano T
    Diabetes; 1998 Jan; 47(1):13-23. PubMed ID: 9421369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo studies of a naturally occurring variant of the human p85alpha regulatory subunit of the phosphoinositide 3-kinase: inhibition of protein kinase B and relationships with type 2 diabetes, insulin secretion, glucose disappearance constant, and insulin sensitivity.
    Hansen L; Zethelius B; Berglund L; Reneland R; Hansen T; Berne C; Lithell H; Hemmings BA; Pedersen O
    Diabetes; 2001 Mar; 50(3):690-3. PubMed ID: 11246893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2005 Aug; 54(8):2351-9. PubMed ID: 16046301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of PI3K catalytic subunit and Akt isoform deficiency on mTOR and p70S6K activation in myoblasts.
    Matheny RW; Adamo ML
    Biochem Biophys Res Commun; 2009 Dec; 390(2):252-7. PubMed ID: 19799871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SH3 domain of the phosphatidylinositol 3-kinase regulatory subunit is responsible for the formation of a sequestration complex with insulin receptor substrate-1.
    Ikegami Y; Inukai K; Awata T; Asano T; Katayama S
    Biochem Biophys Res Commun; 2008 Jan; 365(3):433-8. PubMed ID: 17991427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation.
    Sopasakis VR; Liu P; Suzuki R; Kondo T; Winnay J; Tran TT; Asano T; Smyth G; Sajan MP; Farese RV; Kahn CR; Zhao JJ
    Cell Metab; 2010 Mar; 11(3):220-30. PubMed ID: 20197055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase.
    Terauchi Y; Tsuji Y; Satoh S; Minoura H; Murakami K; Okuno A; Inukai K; Asano T; Kaburagi Y; Ueki K; Nakajima H; Hanafusa T; Matsuzawa Y; Sekihara H; Yin Y; Barrett JC; Oda H; Ishikawa T; Akanuma Y; Komuro I; Suzuki M; Yamamura K; Kodama T; Suzuki H; Yamamura K; Kodama T; Suzuki H; Koyasu S; Aizawa S; Tobe K; Fukui Y; Yazaki Y; Kadowaki T
    Nat Genet; 1999 Feb; 21(2):230-5. PubMed ID: 9988280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.
    Jia S; Liu Z; Zhang S; Liu P; Zhang L; Lee SH; Zhang J; Signoretti S; Loda M; Roberts TM; Zhao JJ
    Nature; 2008 Aug; 454(7205):776-9. PubMed ID: 18594509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.